BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 206 filers reported holding BEAM THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,180,391 | -0.7% | 340,141 | +31.8% | 0.05% | +4.3% |
| Q2 2023 | $8,237,653 | +27.1% | 257,991 | +21.9% | 0.05% | +4.5% |
| Q1 2023 | $6,481,274 | -14.9% | 211,668 | +8.7% | 0.04% | -31.2% |
| Q4 2022 | $7,615,695 | +29.0% | 194,725 | +57.1% | 0.06% | +1.6% |
| Q3 2022 | $5,904,000 | +26.1% | 123,925 | +2.4% | 0.06% | +46.5% |
| Q2 2022 | $4,683,000 | -9.6% | 120,973 | +33.8% | 0.04% | +38.7% |
| Q1 2022 | $5,179,000 | -11.9% | 90,383 | +22.5% | 0.03% | 0.0% |
| Q4 2021 | $5,879,000 | +136.2% | 73,779 | +157.9% | 0.03% | +82.4% |
| Q3 2021 | $2,489,000 | -34.2% | 28,606 | -2.7% | 0.02% | -29.2% |
| Q2 2021 | $3,783,000 | +39.6% | 29,390 | -13.2% | 0.02% | +26.3% |
| Q1 2021 | $2,710,000 | +206.6% | 33,854 | +212.7% | 0.02% | +111.1% |
| Q4 2020 | $884,000 | – | 10,825 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HSG Holding Ltd | 1,127,934 | $31,582,000 | 5.60% |
| Omega Fund Management, LLC | 302,821 | $8,479,000 | 2.32% |
| Redmile Group, LLC | 3,356,958 | $93,995,000 | 1.74% |
| BRANDYWINE MANAGERS, LLC | 10,875 | $305,000 | 1.25% |
| DC Investments Management, LLC | 88,100 | $2,467,000 | 0.91% |
| Alphabet Inc. | 663,691 | $18,583,000 | 0.86% |
| Cormorant Asset Management, LP | 796,429 | $22,036,000 | 0.84% |
| HHLR ADVISORS, LTD. | 2,966,403 | $83,059,000 | 0.76% |
| Temasek Holdings (Private) Ltd | 3,354,641 | $93,930,000 | 0.56% |
| Granahan Investment Management | 96,598 | $2,705,000 | 0.10% |